November is Diabetes Awareness Month; it’s a disease that affects millions of people across the United States – both with ...

Zucara Therapeutics Inc., a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with diabetes, announced that ...

If Kennedy is confirmed, we may lower our US vaccine sales estimates, although we don’t think reductions would be ...

The context: Last week, shares in US vaccine manufacturers Pfizer and Moderna, as well as in European counterparts GSK and ...

New research published by the European Federation of Industries and Associations (EFPIA) provides in-depth analysis of the ...

Jasper Therapeutics, Inc.'s Briquilimab shows promise in treating chronic urticaria and asthma, with potential market ...

Sanofi's Chief Digital Officer Emmanuel Frenehard had a thought that he just couldn't shake: how can Sanofi extend the ...

Cassava Sciences, Inc. (NASDAQ: SAVA), a clinical-stage biotechnology company focused on developing a novel treatment for ...

Rob Koremans, CEO of Italian pharmaceutical company Recordati, weighs in on the company's purchase of Sanofi's rare immune ...

Nifty moved in a tight range of 82 points, and ended slightly below the psychologically crucial level of 15,700. NEW DELHI: ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

The White House appointment of the anti-vax conspiracy theorist is devastating ASX healthcare and biotech shares as he ...